Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for which there is currently no cure.

Related posts:

  1. Medicare Card, NIH-funded study points way forward for retinal disease gene therapy Medicare Card, NIH-funded study points way forward for retinal disease gene therapy...
  2. Gene therapy helps patients with hemophilia B An experimental gene therapy technique boosted the production of a vital blood clotting factor in six people with hemophilia B, according to new research supported by the National Institutes of Health. The therapy could give patients a long-term solution for preventing prolonged bleeding episodes and spontaneous bleeding....
  3. Medicare Card, Risk gene for Alzheimer’s disease associated with lower brain amyloid Medicare Card, Risk gene for Alzheimer’s disease associated with lower brain amyloid...
  4. Medicare Card, Gene hastens kidney disease progression in African-Americans A gene variant common in African-Americans predicts that people with that gene who also have chronic kidney disease (CKD) are twice as likely to progress to kidney failure as African-Americans without the high-risk gene and white people with CKD. People with the high-risk gene also tend to lose kidney function at twice the rate of […]...
  5. Medicare Card, Couple’s Therapy Appears to Decrease PTSD Symptoms, Improve Relationship Medicare Card, Couple’s Therapy Appears to Decrease PTSD Symptoms, Improve Relationship...
  6. Medicare Card, Chelation therapy Medicare Card, Chelation therapy ...
  7. Gene replacement treats copper deficiency disorder in mice Gene therapy plus an injection of copper dramatically improved survival in mice with a condition that mimics the often fatal childhood disorder Menkes disease, according to a study by researchers at the National Institutes of Health....
  8. Researchers extend use of gene therapy to treat a soft tissue tumor Researchers extend use of gene therapy to treat a soft tissue tumor...
  9. Researchers restore children’s immune systems with refinements in gene therapy Researchers have demonstrated that a refined gene therapy approach safely restores the immune systems of some children with severe combined immunodeficiency (SCID). The rare condition blocks the normal development of a newborn’s immune system, leaving the child susceptible to every passing microbe. Children with SCID experience chronic infections, which usually triggers the diagnosis. Their lifespan […]...
  10. Medicare, New website: Clinical Research Trials and You The National Institutes of Health has created a new website, NIH Clinical Research Trials and You to help people learn more about clinical trials, why they matter, and how to participate....
  11. Medicare Card, NIH investigators discover new gene that affects clearance of hepatitis C virus Medicare Card, NIH investigators discover new gene that affects clearance of hepatitis C virus...
  12. Medicare Card, Study reveals how genetic changes lead to familial Alzheimer’s disease Medicare Card, Study reveals how genetic changes lead to familial Alzheimer’s disease...
  13. Medicare Card: Gene Linked to Alzheimer’s Disease Plays Key Role in Cell Survival Scientists have discovered that a gene linked to Alzheimer’s disease may play a beneficial role in cell survival by enabling neurons to clear away toxic proteins. A study funded by the National Institute on Aging (NIA), part of the National Institutes of Health, shows the presenilin 1 (PS1) gene is essential to the function of […]...
  14. Concentrated saline therapy not effective in young children with cystic fibrosis Inhaling concentrated saline (salt water) mist does not reduce how often infants and young children with cystic fibrosis (CF) need antibiotics for respiratory symptoms, according to findings from a clinical trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health....
  15. Medicare, NIH scientists identify possible gene target for treating a form of lymphoma Researchers have identified a mutation in a gene that could lead to targeted therapies for certain lymphoma patients whose cure rates are currently poor. Mutation of the MYD88 gene was found to be one of the most frequent genetic abnormalities in a form of cancer known as diffuse large B cell lymphoma. MYD88 encodes a […]...